CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company
Tessera Defense & Homeland Security Inc.
Sign in to watch- Ticker
- HLSQ
- Exchange
- NYSE
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823364020
- Phone
- 972 545610935
- Business address
- 850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
- Former names
- BiomX Inc., Chardan Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-11 | Wolfson Marina Chief Financial Officer | Grant or award · Common Stock Options - Right to Buy | +950,000 | 950,000 | ||
| 2024-07-11 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - Right to Buy | +3,805,000 | 3,805,000 | ||
| 2024-07-11 | LEFF JONATHAN S Director | Grant or award · Common Stock Options - Right to Buy | +264,000 | 264,000 | ||
| 2024-07-11 | GOODMAN JESSE Director | Grant or award · Common Stock Options - Right to Buy | +264,000 | 264,000 | ||
| 2024-07-11 | Merril Gregory Louis Director | Grant or award · Common Stock Options - Right to Buy | +264,000 | 264,000 | ||
| 2024-07-11 | Williams Eddie Director | Grant or award · Common Stock Options - Right to Buy | +176,000 | 176,000 | ||
| 2024-07-11 | Oron Assaf Chief Business Officer | Grant or award · Common Stock Options - Right to Buy | +237,500 | 237,500 | ||
| 2024-07-11 | Moses Alan Charles Director | Grant or award · Common Stock Options - Right to Buy | +176,000 | 176,000 | ||
| 2024-07-11 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +264,000 | 264,000 | ||
| 2024-07-09 | Flynn James E Director | Grant or award · Warrants | +722,175 | 722,175 | ||
| 2024-07-09 | Flynn James E Director | Grant or award · Warrants | +722,175 | 722,175 | ||
| 2024-07-09 | Flynn James E Director | Grant or award · Warrants | +20,175,000 | 20,175,000 | ||
| 2024-07-09 | Flynn James E Director | Grant or award · Warrants | +20,175,000 | 20,175,000 | ||
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership 10% owner | Option exercise | +9,280,408 | $0.24 | $2.3M | 13,797,997 |
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership 10% owner | Sale | −24,344 | $0.38 | $9K | 13,773,653 |
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership 10% owner | Option exercise · Warrants (Right to Buy) | −9,280,408 | 0 | ||
| 2024-05-15 | Cystic Fibrosis Foundation 10% owner | Option exercise | +4,778,265 | $0.00 | $5K | 9,330,580 |
| 2024-05-15 | Cystic Fibrosis Foundation 10% owner | Option exercise · Warrant to purchase common stock | −4,778,265 | 0 | ||
| 2024-03-15 | Flynn James E Director | Grant or award | +3,055,049 | 3,055,049 | ||
| 2024-03-15 | Flynn James E Director | Grant or award | +3,055,049 | 3,055,049 |
Page 4 of 12 · 240 trades